ガンマコロナウイルスの新型ナノ粒子ワクチンの開発と保護効果
Ting Xiong1,2, Yanfen Lyu1,2,3,4,5, Hongmei Li2
1College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.
Vaccines
|August 28, 2025
まとめ
新しいナノ粒子ワクチンは,感染性支気管炎ウイルス (IBV) GI-19 系統から鶏を効果的に保護しました. nAP205- S1ワクチンは優れた免疫反応と100%の保護を誘発し,家禽の健康に希望を示しました.
科学分野:
- 獣医ウイルス学
- 免疫学
- ワクチンのナノテクノロジー
背景:
- 重要なガンマコロナウイルスである感染性支氣管炎ウイルス (IBV) は,世界の家禽産業にとって大きな脅威となっています.
- GI-19の系統が優勢ですが,有効な商用ワクチンは不足しています.
- 現在の制限はIBVに対する新しい予防接種戦略の開発を必要としています.
研究 の 目的:
- IBV の GI-19 系統に対する新しいナノ粒子ベースのワクチンの開発と評価.
- ナノ粒子ワクチン (nAP205-S1) とサブユニットワクチン (S1-SpyTag) の免疫性および保護効果を比較する.
- ウイルスの脅威に対する 免疫反応と 細胞免疫反応の評価
主な方法:
- CHOとE. coliシステムを用いてS1-SpyTagとAP205-SpyCatcherタンパク質の発現
- 精製されたタンパク質をNAP205-S1ナノ粒子 (nAP205-S1) に自己組み立て
- nAP205-S1とS1-SpyTagを,SPF鶏の免疫用油添加剤ワクチンの配方とする.
主要な成果:
- nAP205- S1ナノ粒子のワクチンは,チキンにおける強固なIBV特有の体内および細胞免疫反応を誘発した.
- nAP205- S1によって引き起こされた免疫反応は,特に細胞免疫は,S1- SpyTagワクチンによるものより有意に強力でした.
- nAP205- S1によるワクチン接種は,感染に対する集団の100%の保護をもたらし,ウイルスの流出を効果的に減少させた.
結論:
- 開発されたAP205-S1ナノ粒子ワクチンは,GI-19 IBVに対する重要な保護の可能性を示しています.
- この新しいナノ粒子ワクチン戦略は 家禽に広範囲にわたる 防御的な免疫を 開発するための有望なアプローチです
- 更に発展すれば,経済的に重要なIBV系統に対する 有効な商用ワクチンが作れるでしょう.
さらに関連する動画
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.7K
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.9K
関連する概念動画
Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Vaccine Production
144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
